IAG’ Strengthens its Clinical Trial Operations Team
IAG, Image Analysis Group announced today the expansion of its Clinical Trial Operations team and welcomed Michael Clark, VP of Business and Clinical Trial Operations and Sébastien Jacques, Sn Project Manager Oncology Clinical Research.
Sébastien Jacques, MSc, MPM is an experienced project manager with a demonstrated history of working in the pharmaceuticals industry and a technical expert with background in software engineering and information technology. He brings 12+ years of experience in program & portfolio management of global multicentre trials in solid tumours, bladder, BTC, cholangiocarcinoma, HCC, NSCLC, pancreatic adenocarcinoma and other oncology indications. Sebastien will join IAG’s team to support our biotech and pharma customers’ clinical development projects.
Michael Clark, will be taking a leadership management role and oversee the strategic planning and execution of clinical programs as well as global expansion of IAG’s operations.
‘We warmly welcome the new team members, whose passion to quality and science and commitment to achieving and exceeding targets resonate incredibly well with the rest of the organization’, said Dr. Olga Kubassova, IAG’s CEO.
‘As the team growth, we look forward to exciting 2019 and anticipate rapid growth both in Europe and USA,’ add Dr Christophe Berthoux, chairman of IAG.
Both, Michael and Sébastien start in January 2019 and will be supporting IAG’s global clinical research programs and operations.
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: www.ia-grp.com
Reach out: firstname.lastname@example.org
Follow the Company: Linkedin
Drug development ideas in osteoarthritis, psoriatic arthritis and scleroderma.
The Invitation-only network for founders &CEOs of the most successful scaleups.
Dr Kubassova is a leading innovator and passionate investor in healthcare.
Presenting new data from Ulcerative Colitis trial at DDW 2023.